Gene · 7334
Papers2,223
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,223
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TAF15 inhibits p53 nucleus translocation and promotes HCC cell 5-FU resistance via post-transcriptional regulation of UBE2N. | J Physiol Biochem | 2024 | 39446246 | PubTator, text mining | PubMed |
| Hsa_circ_0000520 suppresses vasculogenic mimicry formation and metastasis in bladder cancer through Lin28a/PTEN/PI3K signaling. | Cell Mol Biol Lett | 2024 | 39237880 | PubTator, text mining | PubMed |
| Dysregulation of Toll-Like Receptor Signaling-Associated Gene Expression in X-Linked Agammaglobulinemia: Implications for Correlations Genotype-Phenotype and Disease Expression. | J Innate Immun | 2024 | 39116841 | PubTator, text mining | PubMed |
| Inhibition of K63 ubiquitination by G-Protein pathway suppressor 2 (GPS2) regulates mitochondria-associated translation. | Pharmacol Res | 2024 | 39094987 | PubTator, text mining | PubMed |
| Suppressing UBE2N ameliorates Alzheimer's disease pathology through the clearance of amyloid beta. | Alzheimers Dement | 2024 | 39015037 | PubTator, text mining | PubMed |
| Unconventional posttranslational modification in innate immunity. | Cell Mol Life Sci | 2024 | 38970666 | PubTator, text mining | PubMed |
| Validating the temporal performance of genetic biomarkers in an animal model of recurrence/ non-recurrence myocardial infarction persuades by bioinformatics tools. | Eur J Pharmacol | 2024 | 38950836 | PubTator, text mining | PubMed |
| A RAD18-UBC13-PALB2-RNF168 axis mediates replication fork recovery in BRCA1-deficient cancer cells. | Nucleic Acids Res | 2024 | 38943334 | PubTator, text mining | PubMed |
| MRNIP limits ssDNA gaps during replication stress. | Nucleic Acids Res | 2024 | 38917325 | PubTator, text mining | PubMed |
| Dysregulated innate immune signaling cooperates with RUNX1 mutations to transform an MDS-like disease to AML. | iScience | 2024 | 38784013 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals PRKCA as a potential therapeutic target for overcoming cisplatin resistance in lung cancer through ferroptosis. | Heliyon | 2024 | 38765024 | PubTator, text mining | PubMed |
| Pirh2 modulates the mitochondrial function and cytochrome c-mediated neuronal death during Alzheimer's disease. | Cell Death Dis | 2024 | 38740775 | PubTator, text mining | PubMed |
| UBE2N promotes cell viability and glycolysis by promoting Axin1 ubiquitination in prostate cancer cells. | Biol Direct | 2024 | 38715121 | PubTator, text mining | PubMed |
| Global, site-resolved analysis of ubiquitylation occupancy and turnover rate reveals systems properties. | Cell | 2024 | 38626770 | PubTator, text mining | PubMed |
| Integrative experimental validation of concomitant miRNAs and transcription factors with differentially expressed genes in acute myocardial infarction. | Eur J Pharmacol | 2024 | 38552938 | PubTator, text mining | PubMed |
| The emerging roles of non-canonical ubiquitination in proteostasis and beyond. | J Cell Biol | 2024 | 38517379 | PubTator, text mining | PubMed |
| Unique E2-binding specificity of artificial RING fingers in cancer cells. | Sci Rep | 2024 | 38291082 | PubTator, text mining | PubMed |
| Uncovering the mechanisms of MuRF1-induced ubiquitylation and revealing similarities with MuRF2 and MuRF3. | Biochem Biophys Rep | 2024 | 38283190 | PubTator, text mining | PubMed |
| Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation. | Biomark Res | 2024 | 38273355 | PubTator, text mining | PubMed |
| Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis. | Int J Mol Sci | 2024 | 38255946 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7334/papers?page=4